| Application no. and date | 05850906.8 (espacenet) (Federated) (European Patent Register), 20051222 | | Patent/reg. no. and date | DK/EP 1833791, 20110803 | | Publication date | 20070919 | | Priority no. and date | WO PCT/EP2004/014719, 20041227 | | EP pub. no. and date |
EP 1833791 20070919 | | Effective date | | | Applicant/owner | Actelion Pharmaceuticals Ltd., Gewerbestrasse 16
4123 Allschwil, CH | | Applicant ref. no. | P48991DK01 | | Inventor | FRETZ, Heinz, Grenzacherweg 295
CH-4125 Riehen, CH,
RIEDERER, Markus, Friedensstrasse 4
CH-4410 Liestal, CH,
FECHER, Anja, Ochsengasse 18
CH-4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/404 (2006.01) , A61P 37/00 (2006.01) , C07D 209/88 (2006.01) | | Title | 2,3,4,9-tetrahydro-1H-carbazolderivater som CRTH2 receptorantagonister | | Int. application no. | IB2005054380 | | Int. publication no. | WO2006070325 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
